Navigation Links
Decision Diagnostic Corp. Clarifies 10% Stock Dividend, Announces Patent Enforcement Strategy

LOS ANGELES, Dec. 27, 2011 /PRNewswire/ -- Decision Diagnostics Corp., formerly known as InstaCare Corp., (OTCQB: ISCRD), a leading provider of prescription diagnostics, home testing products for the chronically ill, a leading fulfillment provider of direct to patient diabetes programs, and a leading developer of revolutionary cell phone centric e-health products and technologies, today announced that its previously announced 10% Stock Dividend will be Ex-Dividend to all shareholders of record on December 28, 2011.  The Dividend payment date will be December 30, 2011.

Mr. Berman, CFO and Secretary commented, "the stock Dividend is designed to enhance the visibility of the company, improve liquidity, and reward our loyal shareholders.  This Dividend and the changes to the company's capital structure are part of an effort to qualify to have our common stock to be listed on a national exchange, with the goal of applying to the NASDAQ Bx exchange in 2012."

Decision Diagnostics also announced that the company acquired another small engineering oriented company, Sensor Concepts, LLC, an electro-chemistry concepts company.  In addition, the company announced that they have formulated a patent enforcement strategy to coincide with the expected near term grant of the patent for the company's MD@Hand technologies.

Mr. Berman continued, "the Board will continue to evaluate other acquisitions that would add to the company's depth in the at-home diagnostics channel, while we conclude the FDA 510k approval process for Shasta Genstrip. We will have more to say about our new patent enforcement strategies in the coming days."

For more information about Decision Diagnostics Corp. and its revolutionary MD@Hand cell phone centric technologies, and, Pharma Tech Solutions, Inc. and its Shasta Genstrip, please visit the Decision Diagnostics web site or the Pharma Tech web site, or call the company at (805) 446-2973.

Forward-Looking Statements

This news release contains forward-looking statements about our business, or financial condition and prospects that reflect our assumptions and beliefs based on information currently available. We can give no assurance that the expectations indicated by such forward-looking statements will be realized. There may be other risks and circumstances that we are unable to predict. When used in this news release, words such as "believes," "expects," "intends," "plans," "anticipates," "estimates" and similar expressions are intended to identify forward-looking statements, although there may be certain forward-looking statements not accompanied by such expressions.

SOURCE Decision Diagnostics Corp.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Catholic Health Association Applauds HHS Decision on Plan B
2. Decision Diagnostic Corp. (Formerly InstaCare) Announces 10% Stock Dividend
3. FDA Commissioner announces Avastin decision
4. Sanofi Pasteur Launches Nationwide Education Campaign to Help Parents Make Informed Decisions about Immunization
5. Pharmaceutical Executives Use New Search Function for Data-Informed Decision-Making
6. e-Zassi and UBM Canon Partner to Provide Online Medical Device Decision Support Tools at
7. American College of Medical Genetics Applauds HHS Secretarys Decision to Expand Newborn Screening to Include Critical Congenital Heart Disease
8. Experis Recognizes National Healthcare IT Week, Provides Tips for ICD-10 Assessment Decision
9. QIAGEN Completes Second U.S.Submission for Companion Diagnostic to Guide Treatment Decisions in Colorectal Cancer
10. DecisionView StudyOptimizer 4.3™ Enhances Market-Leading Enrollment Optimization Solution With Greater Visibility Into Site Performance and Cost Forecasting
11. Watson Confirms Favorable Appeals Court Decision in Mucinex(R) Patent Suit
Post Your Comments:
(Date:6/23/2016)... Calif. , June 23, 2016 ... CST on Thursday, July 7, 2016 , , , , ... ) , , , , EXPERT PANELISTS:  , , ... Naik; Senior Industry Analyst, Christi Bird; Senior Industry Analyst, Divyaa Ravishankar ... The global pharmaceutical industry is witnessing an exceptional ...
(Date:6/23/2016)... 23, 2016  Astellas today announced the establishment of Astellas Farma Colombia (AFC), a new affiliate with operations headquartered ... Latin America . ... ... ... ...
(Date:6/23/2016)... 2016  Guerbet announced today that it has been ... Award . One of 12 suppliers to ... its support of Premier members through exceptional local customer ... commitment to lower costs. ... our outstanding customer service from Premier," says Massimo ...
Breaking Medicine Technology:
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is ... associated with chronic pain and the benefits of holistic treatments, Serenity Recovery Center ... suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a disorder of ...
(Date:6/24/2016)... ... 2016 , ... Global law firm Greenberg Traurig, P.A. announced that 20 Florida ... their peers for this recognition are considered among the top 2 percent of lawyers ... as members of this year’s Legal Elite Hall of Fame: Miami Shareholders Mark ...
(Date:6/24/2016)... ... ... of Topricin and MyPainAway Pain Relief Products, join The ‘Business for a Fair Minimum Wage’ ... 2020 and then adjusting it yearly to increase at the same rate as the median ... floor does not erode again, and make future increases more predictable. , The company is ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Haute ... Dr. Barry M. Weintraub as a prominent plastic surgeon and the network’s newest ... world, and the most handsome men, look naturally attractive. Plastic surgery should be ...
(Date:6/24/2016)... ... ... National recruitment firm Slone Partners is pleased to announce the ... as Vice President of North American Capital Sales at HTG Molecular . ... team in the commercialization of the HTG EdgeSeq system and associated reagents in North ...
Breaking Medicine News(10 mins):